Stephen J Tulipano Stoke Therapeutics, Inc. (STOK) insider trading activity

STOK Quotes by TradingView

Stephen J Tulipano is Former CFO of Stoke Therapeutics, Inc.. Currently has a direct ownership of 20,746 shares of STOK, which is worth approximately $280,278. The most recent transaction as insider was on Mar 19, 2024, when has been sold 4,116 shares (Common Stock) at a price of $6.1 per share, resulting in proceeds of $25,107. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K
0% 3M change
76.38% 12M change
Total Value Held $280,278

Stephen J Tulipano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2024
SELL
Open market or private sale
$25,107 $6.1 p/Share
4,116 Reduced 16.56%
20,746 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
13,100 Added 34.51%
24,862 Common Stock
Jun 02 2022
BUY
Exercise of conversion of derivative security
$49,997 $4.48 p/Share
11,160 Added 48.69%
11,762 Common Stock
Feb 23 2021
SELL
Open market or private sale
$293,000 $58.6 p/Share
5,000 Reduced 89.25%
602 Common Stock
Feb 23 2021
BUY
Exercise of conversion of derivative security
$22,400 $4.48 p/Share
5,000 Added 47.16%
5,602 Common Stock
Feb 22 2021
SELL
Open market or private sale
$1,483,000 $59.32 p/Share
25,000 Reduced 97.65%
602 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$112,000 $4.48 p/Share
25,000 Added 49.41%
25,602 Common Stock
Nov 04 2020
SELL
Open market or private sale
$1,368,645 $41.14 p/Share
33,268 Reduced 98.22%
602 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$149,041 $4.48 p/Share
33,268 Added 49.55%
33,870 Common Stock
Nov 03 2020
SELL
Open market or private sale
$69,003 $39.84 p/Share
1,732 Reduced 74.21%
602 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$7,759 $4.48 p/Share
1,732 Added 42.6%
2,334 Common Stock
Nov 02 2020
SELL
Open market or private sale
$1,319,500 $37.7 p/Share
35,000 Reduced 98.31%
602 Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$156,800 $4.48 p/Share
35,000 Added 49.57%
35,602 Common Stock
SJT

Stephen J Tulipano

Former CFO
Bedford, MA

Track Institutional and Insider Activities on STOK

Follow Stoke Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

News

Receive news related to Stoke Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on STOK